Ignite Creation Date:
2024-05-05 @ 11:53 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01446159
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2011-09-12
Brief Title:
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hormone-sensitive HER-2 Negative Metastatic Breast Cancer |
Keywords:
| Name | View |
|---|---|
| MEDI-573 breast cancer metastatic aromatase inhibitor anti-IGF | View |